Genomic and Histopathological Tissue Biomarkers That Predict Radiotherapy Response in Localised Prostate Cancer

Localised prostate cancer, in particular, intermediate risk disease, has varied survival outcomes that cannot be predicted accurately using current clinical risk factors. External beam radiotherapy (EBRT) is one of the standard curative treatment options for localised disease and its efficacy is rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilkins, Anna, Dearnaley, David, Somaiah, Navita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609338/
https://www.ncbi.nlm.nih.gov/pubmed/26504789
http://dx.doi.org/10.1155/2015/238757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609338/
https://www.ncbi.nlm.nih.gov/pubmed/26504789
http://dx.doi.org/10.1155/2015/238757

Ejemplares similares